143 related articles for article (PubMed ID: 35178099)
1. Molecular Assessment of
Shi H; Liu J; Fan J; He L; Wang X; Tang F; Tian D; He Y
Evid Based Complement Alternat Med; 2022; 2022():1988378. PubMed ID: 35178099
[TBL] [Abstract][Full Text] [Related]
2. Study on the mechanism of action of
Yang AY; Liu HL; Yang YF
Front Pharmacol; 2022; 13():1072547. PubMed ID: 36699068
[No Abstract] [Full Text] [Related]
3. [Mechanism of "Scutellaria barbata-Hedyotis diffusa" against breast cancer based on network pharmacology].
Jing XU; Feng-Qin S; Ke-Xin DU; Jia D; Dong-Yun LI
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4448-4454. PubMed ID: 33164375
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification.
Zhang J; Qi C; Li H; Ding C; Wang L; Wu H; Dai W; Wang C
Medicine (Baltimore); 2023 Dec; 102(51):e36656. PubMed ID: 38134066
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology-based strategy to investigate the active ingredients and molecular mechanisms of Scutellaria Barbata D. Don against radiation pneumonitis.
Sun PY; Wang AS; Zhang ZF; Zhang YL; Zheng X
Medicine (Baltimore); 2021 Nov; 100(47):e27957. PubMed ID: 34964782
[TBL] [Abstract][Full Text] [Related]
6. Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking.
Fan JY; Liu J; Zhang WQ; Lin T; Hu XR; Zhou FL; Tang L; He YC; Shi HJ
Medicine (Baltimore); 2023 Dec; 102(48):e36477. PubMed ID: 38050231
[TBL] [Abstract][Full Text] [Related]
7. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
8. Luteolin Isolated from
Xiong Y; Zhong W; Liu J; Cheng B; Fan J; Zhou F; He L; Tian D; He Y
Biomed Res Int; 2022; 2022():9740066. PubMed ID: 36588531
[TBL] [Abstract][Full Text] [Related]
9. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
10. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking and network pharmacological analysis of Scutellaria baicalensis against renal cell carcinoma.
Guo J; Mei ZW; Wang XJ; Li Q; Qin J
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11574-11586. PubMed ID: 38095405
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Molecular Mechanism of
Xu R; Yang X; Tao Y; Luo W; Xiong Y; He L; Zhou F; He Y
J Healthc Eng; 2022; 2022():6277139. PubMed ID: 35463684
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Active Ingredients and Mechanism of
Bi J; Lin Y; Sun Y; Zhang M; Chen Q; Miu X; Tang L; Liu J; Zhu L; Ni Z; Wang X
Drug Des Devel Ther; 2021; 15():1075-1089. PubMed ID: 33727796
[TBL] [Abstract][Full Text] [Related]
14. AURKB, CHEK1 and NEK2 as the Potential Target Proteins of
Huang C; Luo H; Huang Y; Fang C; Zhao L; Li P; Zhong C; Liu F
Int J Gen Med; 2021; 14():3295-3312. PubMed ID: 34285555
[TBL] [Abstract][Full Text] [Related]
15. Molecular Targets and Mechanisms of
Yang Z; Lu S; Tang H; Qu J; Wang B; Wang Y; Pan G; Rao B
Evid Based Complement Alternat Med; 2022; 2022():6186662. PubMed ID: 35707465
[No Abstract] [Full Text] [Related]
16. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology to Uncover the Molecular Mechanisms of Action of LeiGongTeng for the Treatment of Nasopharyngeal Carcinoma.
Mi JL; Liu C; Xu M; Wang RS
Med Sci Monit Basic Res; 2020 May; 26():e923431. PubMed ID: 32448862
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effect of Scutellaria barbata D. Don extracts on ovarian cancer and its phytochemicals characterisation.
Zhang L; Ren B; Zhang J; Liu L; Liu J; Jiang G; Li M; Ding Y; Li W
J Ethnopharmacol; 2017 Jul; 206():184-192. PubMed ID: 28571726
[TBL] [Abstract][Full Text] [Related]
19. A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.
Wang T; Lyu CY; Jiang YH; Dong XY; Wang Y; Li ZH; Wang JX; Xu RR
Mol Divers; 2021 Nov; 25(4):2351-2365. PubMed ID: 32676746
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
